SEARCH RESULT

Total Matching Records found : 4778

Sen vs Bhagwati: Parallels from an earlier titanic clash-Rupa Subramanya

-The Business Standard Can Bhagwati-Sen debate bring the same change as Hayek-Keynes duel in the US in 1932 At a time of economic crisis, a distinguished group of economists wrote a letter to a major newspaper, making a case for increased government involvement in the economy. A few days later, an equally distinguished group of economists wrote a letter to the same newspaper, arguing against the first lot. No, this...

More »

Steep drop in number of poor gifts UPA talking point, raises eyebrows

-The Telegraph New Delhi: The Manmohan Singh-led UPA government can finally grab an official statistic to burnish its aam aadmi credentials. The percentage of people living below the poverty line has fallen to 21.9 per cent of the population in 2011-12 from 37.2 per cent in 2004-05 - the year that the Congress-led UPA stormed to power. The percentage of people below the poverty line has been estimated at 25.7 per cent in...

More »

Of politicians and some verdicts -N Gopalaswami

-The Hindu Court rulings on freebies, elections and caste-based rallies, and the CIC order on political parties are a beginning towards cleansing politics but whether they can achieve the desired result is debatable The slew of judgments from the higher judiciary in the period of just about a month or so has been like manna from heaven on the parched earth of electoral reforms. First, the Supreme Court frowned upon freebies, which...

More »

Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian pharma-Ramesh Adige

-The Economic Times Over a year ago, I had written a piece, Quo Vadis, Indian Pharma? (ET, May 11, 2012), in this column. Some key issues were highlighted in the article. Perhaps it is time to revisit the subject and bring out some current issues. Price control: Hurray, the department of pharmaceuticals has come out with a new non-intrusive price control methodology, moving from the cost-based model to the average market price...

More »

WHO accused of promoting 'deadly' vaccine in India -KS Jayaraman

-IANS Bangalore: A leading journal of medical ethics has charged the World Health Organization (WHO) with promoting the Pentavalent vaccine in countries, including India, though it is known to have caused adverse reactions and deaths in children. In a hard-hitting editorial, the latest issue of the Indian Journal of Medical Ethics (IJME), has accused the WHO of promoting the vaccine "by stating falsely that no adverse event following immunisation (AEFI) has ever...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close